Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Mechanistic insights into self-reinforcing processes driving abnormal histogenesis during the development of pancreatic cancer.

Iovanna JL, Marks DL, Fernandez-Zapico ME, Urrutia R.

Am J Pathol. 2013 Apr;182(4):1078-86. doi: 10.1016/j.ajpath.2012.12.004. Epub 2013 Jan 31. Review.

2.

Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray.

Maitra A, Adsay NV, Argani P, Iacobuzio-Donahue C, De Marzo A, Cameron JL, Yeo CJ, Hruban RH.

Mod Pathol. 2003 Sep;16(9):902-12.

3.

Maintenance of acinar cell organization is critical to preventing Kras-induced acinar-ductal metaplasia.

Shi G, DiRenzo D, Qu C, Barney D, Miley D, Konieczny SF.

Oncogene. 2013 Apr 11;32(15):1950-8. doi: 10.1038/onc.2012.210. Epub 2012 Jun 4.

4.

Interleukin-6: a villain in the drama of pancreatic cancer development and progression.

Holmer R, Goumas FA, Waetzig GH, Rose-John S, Kalthoff H.

Hepatobiliary Pancreat Dis Int. 2014 Aug;13(4):371-80. Review.

PMID:
25100121
5.

Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.

Aichler M, Seiler C, Tost M, Siveke J, Mazur PK, Da Silva-Buttkus P, Bartsch DK, Langer P, Chiblak S, Dürr A, Höfler H, Klöppel G, Müller-Decker K, Brielmeier M, Esposito I.

J Pathol. 2012 Apr;226(5):723-34. doi: 10.1002/path.3017. Epub 2012 Jan 17.

PMID:
21984419
6.

The epigenetic regulators Bmi1 and Ring1B are differentially regulated in pancreatitis and pancreatic ductal adenocarcinoma.

Martínez-Romero C, Rooman I, Skoudy A, Guerra C, Molero X, González A, Iglesias M, Lobato T, Bosch A, Barbacid M, Real FX, Hernández-Muñoz I.

J Pathol. 2009 Oct;219(2):205-13. doi: 10.1002/path.2585.

PMID:
19585519
7.

NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas.

Chen NM, Singh G, Koenig A, Liou GY, Storz P, Zhang JS, Regul L, Nagarajan S, Kühnemuth B, Johnsen SA, Hebrok M, Siveke J, Billadeau DD, Ellenrieder V, Hessmann E.

Gastroenterology. 2015 May;148(5):1024-1034.e9. doi: 10.1053/j.gastro.2015.01.033. Epub 2015 Jan 23.

8.

An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression.

Kim J, Hoffman JP, Alpaugh RK, Rhim AD, Reichert M, Stanger BZ, Furth EE, Sepulveda AR, Yuan CX, Won KJ, Donahue G, Sands J, Gumbs AA, Zaret KS.

Cell Rep. 2013 Jun 27;3(6):2088-99. doi: 10.1016/j.celrep.2013.05.036. Epub 2013 Jun 20. Erratum in: Cell Rep. 2013 Jul 25;4(2):403. Rhimm, Andrew D [corrected to Rhim, Andrew D].

9.

Assessment of the stromal contribution to Sonic Hedgehog-dependent pancreatic adenocarcinoma.

Damhofer H, Medema JP, Veenstra VL, Badea L, Popescu I, Roelink H, Bijlsma MF.

Mol Oncol. 2013 Dec;7(6):1031-42. doi: 10.1016/j.molonc.2013.08.004. Epub 2013 Aug 16.

10.

Pancreatic tumor cell metabolism: focus on glycolysis and its connected metabolic pathways.

Guillaumond F, Iovanna JL, Vasseur S.

Arch Biochem Biophys. 2014 Mar 1;545:69-73. doi: 10.1016/j.abb.2013.12.019. Epub 2014 Jan 3. Review.

PMID:
24393743
11.

The role of hypoxia in pancreatic cancer: a potential therapeutic target?

Erkan M, Kurtoglu M, Kleeff J.

Expert Rev Gastroenterol Hepatol. 2016;10(3):301-16. doi: 10.1586/17474124.2016.1117386. Epub 2015 Nov 27. Review.

PMID:
26560854
12.

Pancreatic adenocarcinoma: general histological overview.

Demetter P, D'Haene N, Verset L, Nagy N.

Acta Chir Belg. 2013 Mar-Apr;113(2):71-6. Review.

PMID:
23741925
13.

[Precursors to pancreatic cancer].

Søreide K, Immervoll H, Molven A.

Tidsskr Nor Laegeforen. 2006 Mar 23;126(7):905-8. Review. Norwegian.

14.

A bioengineered heterotypic stroma-cancer microenvironment model to study pancreatic ductal adenocarcinoma.

Drifka CR, Eliceiri KW, Weber SM, Kao WJ.

Lab Chip. 2013 Oct 7;13(19):3965-75. doi: 10.1039/c3lc50487e.

15.

Stromal biology of pancreatic cancer.

Chu GC, Kimmelman AC, Hezel AF, DePinho RA.

J Cell Biochem. 2007 Jul 1;101(4):887-907. Review.

PMID:
17266048
16.

Pancreatic cancer microenvironment.

Kleeff J, Beckhove P, Esposito I, Herzig S, Huber PE, Löhr JM, Friess H.

Int J Cancer. 2007 Aug 15;121(4):699-705. Review.

17.

Expression of the ZEB2 gene in pancreatic stromal cells in pancreatic ductal adenocarcinoma, pancreatitis, and normal state.

Usova EV, Kopantseva MR, Kostina MB, Van'kovich AN, Egorov VI, Kopantsev EP.

Dokl Biol Sci. 2013 Jan;448:61-4. doi: 10.1134/S001249661301016X. Epub 2013 Mar 12. No abstract available.

PMID:
23479023
18.

Identification and manipulation of biliary metaplasia in pancreatic tumors.

Delgiorno KE, Hall JC, Takeuchi KK, Pan FC, Halbrook CJ, Washington MK, Olive KP, Spence JR, Sipos B, Wright CV, Wells JM, Crawford HC.

Gastroenterology. 2014 Jan;146(1):233-44.e5. doi: 10.1053/j.gastro.2013.08.053. Epub 2013 Aug 30.

19.

Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma.

Guillaumond F, Leca J, Olivares O, Lavaut MN, Vidal N, Berthezène P, Dusetti NJ, Loncle C, Calvo E, Turrini O, Iovanna JL, Tomasini R, Vasseur S.

Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):3919-24. doi: 10.1073/pnas.1219555110. Epub 2013 Feb 13.

20.

Epithelial-mesenchymal transition in pancreatic cancer: Is it a clinically significant factor?

Jiang JH, Liu C, Cheng H, Lu Y, Qin Y, Xu YF, Xu J, Long J, Liu L, Ni QX, Yu XJ.

Biochim Biophys Acta. 2015 Jan;1855(1):43-9. doi: 10.1016/j.bbcan.2014.11.004. Epub 2014 Nov 26. Review.

PMID:
25432020

Supplemental Content

Support Center